These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Ameliorating the in vivo antimalarial efficacy of artemether using nanostructured lipid carriers. Vanka R; Kuppusamy G; Praveen Kumar S; Baruah UK; Karri VVSR; Pandey V; Babu PP J Microencapsul; 2018 Mar; 35(2):121-136. PubMed ID: 29448884 [TBL] [Abstract][Full Text] [Related]
5. Amphiphilic dendritic derivatives as nanocarriers for the targeted delivery of antimalarial drugs. Movellan J; Urbán P; Moles E; de la Fuente JM; Sierra T; Serrano JL; Fernàndez-Busquets X Biomaterials; 2014 Sep; 35(27):7940-50. PubMed ID: 24930847 [TBL] [Abstract][Full Text] [Related]
6. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Das S; Ng WK; Tan RB Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358 [TBL] [Abstract][Full Text] [Related]
7. PEGylated peptide dendrimeric carriers for the delivery of antimalarial drug chloroquine phosphate. Bhadra D; Bhadra S; Jain NK Pharm Res; 2006 Mar; 23(3):623-33. PubMed ID: 16374532 [TBL] [Abstract][Full Text] [Related]
8. Effective-Loading of Platinum-Chloroquine into PEGylated Neutral and Cationic Liposomes as a Drug Delivery System for Resistant Malaria Parasites. Ibrahim S; Tagami T; Ozeki T Biol Pharm Bull; 2017; 40(6):815-823. PubMed ID: 28566625 [TBL] [Abstract][Full Text] [Related]
9. Development of artemether and lumefantrine co-loaded nanostructured lipid carriers: physicochemical characterization and in vivo antimalarial activity. Parashar D; Aditya NP; Murthy RS Drug Deliv; 2016; 23(1):123-9. PubMed ID: 24786480 [TBL] [Abstract][Full Text] [Related]
10. A Redox-Active Fluorescent pH Indicator for Detecting Plasmodium falciparum Strains with Reduced Responsiveness to Quinoline Antimalarial Drugs. Jida M; Sanchez CP; Urgin K; Ehrhardt K; Mounien S; Geyer A; Elhabiri M; Lanzer M; Davioud-Charvet E ACS Infect Dis; 2017 Feb; 3(2):119-131. PubMed ID: 28183182 [TBL] [Abstract][Full Text] [Related]
11. Design, characterization and skin permeating potential of Fluocinolone acetonide loaded nanostructured lipid carriers for topical treatment of psoriasis. Pradhan M; Singh D; Murthy SN; Singh MR Steroids; 2015 Sep; 101():56-63. PubMed ID: 26049018 [TBL] [Abstract][Full Text] [Related]
12. 3-Iodo-4-aminoquinoline derivative sensitises resistant strains of Plasmodium falciparum to chloroquine. Edaye S; Tazoo D; Bohle DS; Georges E Int J Antimicrob Agents; 2016 Jun; 47(6):482-5. PubMed ID: 27211211 [TBL] [Abstract][Full Text] [Related]
14. Development and characterization of arteether-loaded nanostructured lipid carriers for the treatment of malaria. Ali Z; Mishra N; Baldi A Artif Cells Nanomed Biotechnol; 2016; 44(2):545-9. PubMed ID: 25340261 [TBL] [Abstract][Full Text] [Related]
15. Sustained-release liquisolid compact tablets containing artemether-lumefantrine as alternate-day regimen for malaria treatment to improve patient compliance. Nnamani PO; Ugwu AA; Ibezim EC; Kenechukwu FC; Akpa PA; Ogbonna JN; Obitte NC; Odo AN; Windbergs M; Lehr CM; Attama AA Int J Nanomedicine; 2016; 11():6365-6378. PubMed ID: 27932882 [TBL] [Abstract][Full Text] [Related]
16. Use of poly(amidoamine) drug conjugates for the delivery of antimalarials to Plasmodium. Urbán P; Valle-Delgado JJ; Mauro N; Marques J; Manfredi A; Rottmann M; Ranucci E; Ferruti P; Fernàndez-Busquets X J Control Release; 2014 Mar; 177():84-95. PubMed ID: 24412735 [TBL] [Abstract][Full Text] [Related]
17. Chloroquine-containing organoruthenium complexes are fast-acting multistage antimalarial agents. Macedo TS; Colina-Vegas L; DA Paixão M; Navarro M; Barreto BC; Oliveira PC; Macambira SG; Machado M; Prudêncio M; D'Alessandro S; Basilico N; Moreira DR; Batista AA; Soares MB Parasitology; 2016 Oct; 143(12):1543-56. PubMed ID: 27439976 [TBL] [Abstract][Full Text] [Related]
18. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation. Dudhipala N; Janga KY; Gorre T Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077 [TBL] [Abstract][Full Text] [Related]
19. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration. Song A; Zhang X; Li Y; Mao X; Han F Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734 [TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of silybin-loaded nanostructured lipid carriers. Jia LJ; Zhang DR; Li ZY; Feng FF; Wang YC; Dai WT; Duan CX; Zhang Q Drug Deliv; 2010 Jan; 17(1):11-8. PubMed ID: 19941406 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]